163 related articles for article (PubMed ID: 1408834)
1. Differential ASF/SF2 activity in extracts from normal WI38 and transformed WI38VA13 cells.
Chabot B; Frappier D; La Branche H
Nucleic Acids Res; 1992 Oct; 20(19):5197-204. PubMed ID: 1408834
[TBL] [Abstract][Full Text] [Related]
2. Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors.
Hanamura A; Cáceres JF; Mayeda A; Franza BR; Krainer AR
RNA; 1998 Apr; 4(4):430-44. PubMed ID: 9630249
[TBL] [Abstract][Full Text] [Related]
3. The essential pre-mRNA splicing factor SF2 influences 5' splice site selection by activating proximal sites.
Krainer AR; Conway GC; Kozak D
Cell; 1990 Jul; 62(1):35-42. PubMed ID: 2364434
[TBL] [Abstract][Full Text] [Related]
4. The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.
Dauksaite V; Akusjärvi G
Biochem J; 2004 Jul; 381(Pt 2):343-50. PubMed ID: 15068396
[TBL] [Abstract][Full Text] [Related]
5. Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro.
Cao W; Jamison SF; Garcia-Blanco MA
RNA; 1997 Dec; 3(12):1456-67. PubMed ID: 9404896
[TBL] [Abstract][Full Text] [Related]
6. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
[TBL] [Abstract][Full Text] [Related]
7. Human splicing factor ASF/SF2 encodes for a repressor domain required for its inhibitory activity on pre-mRNA splicing.
Dauksaite V; Akusjärvi G
J Biol Chem; 2002 Apr; 277(15):12579-86. PubMed ID: 11801589
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of essential splicing factor ASF/SF2 blocks the temporal shift in adenovirus pre-mRNA splicing and reduces virus progeny formation.
Molin M; Akusjärvi G
J Virol; 2000 Oct; 74(19):9002-9. PubMed ID: 10982344
[TBL] [Abstract][Full Text] [Related]
9. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation.
Petersen-Mahrt SK; Estmer C; Ohrmalm C; Matthews DA; Russell WC; Akusjärvi G
EMBO J; 1999 Feb; 18(4):1014-24. PubMed ID: 10022843
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA.
Ropers D; Ayadi L; Gattoni R; Jacquenet S; Damier L; Branlant C; Stévenin J
J Biol Chem; 2004 Jul; 279(29):29963-73. PubMed ID: 15123677
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways.
Wang J; Manley JL
RNA; 1995 May; 1(3):335-46. PubMed ID: 7489505
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation-dephosphorylation differentially affects activities of splicing factor ASF/SF2.
Xiao SH; Manley JL
EMBO J; 1998 Nov; 17(21):6359-67. PubMed ID: 9799243
[TBL] [Abstract][Full Text] [Related]
13. Pathways for selection of 5' splice sites by U1 snRNPs and SF2/ASF.
Eperon IC; Ireland DC; Smith RA; Mayeda A; Krainer AR
EMBO J; 1993 Sep; 12(9):3607-17. PubMed ID: 8253084
[TBL] [Abstract][Full Text] [Related]
14. Titration of serine/arginine (SR) splicing factors during adenoviral infection modulates E1A pre-mRNA alternative splicing.
Himmelspach M; Cavaloc Y; Chebli K; Stévenin J; Gattoni R
RNA; 1995 Oct; 1(8):794-806. PubMed ID: 7493325
[TBL] [Abstract][Full Text] [Related]
15. U1 snRNP-ASF/SF2 interaction and 5' splice site recognition: characterization of required elements.
Jamison SF; Pasman Z; Wang J; Will C; Lührmann R; Manley JL; Garcia-Blanco MA
Nucleic Acids Res; 1995 Aug; 23(16):3260-7. PubMed ID: 7667103
[TBL] [Abstract][Full Text] [Related]
16. Pre-mRNA splicing in plants: characterization of Ser/Arg splicing factors.
Lopato S; Mayeda A; Krainer AR; Barta A
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3074-9. PubMed ID: 8610170
[TBL] [Abstract][Full Text] [Related]
17. Deletion of the N-terminus of SF2/ASF permits RS-domain-independent pre-mRNA splicing.
Shaw SD; Chakrabarti S; Ghosh G; Krainer AR
PLoS One; 2007 Sep; 2(9):e854. PubMed ID: 17786225
[TBL] [Abstract][Full Text] [Related]
18. SC35-mediated reconstitution of splicing in U2AF-depleted nuclear extract.
MacMillan AM; McCaw PS; Crispino JD; Sharp PA
Proc Natl Acad Sci U S A; 1997 Jan; 94(1):133-6. PubMed ID: 8990173
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the function of an exonic splicing enhancer after the first catalytic step of pre-mRNA splicing.
Chew SL; Liu HX; Mayeda A; Krainer AR
Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10655-60. PubMed ID: 10485881
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of the SR protein ASF/SF2: interchangeability of RS domains and negative control of splicing.
Wang J; Xiao SH; Manley JL
Genes Dev; 1998 Jul; 12(14):2222-33. PubMed ID: 9679066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
